3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
Neoplasms
7
Leukemia, Myeloid, Acute
7
Lung Neoplasms
5
Ovarian Neoplasms
4
Fatigue
4
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Lymphoma
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Genital Neoplasms, Female
2
Esophageal Neoplasms
2
Depression
2
Weight Loss
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Interventions
Doxorubicin
11
Razoxane
5
Dexrazoxane
5
Electrocardiography
4
Echocardiography
4
Cyclophosphamide
4
Vincristine
3
Trastuzumab
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Exercise
3
Etoposide
3
Carvedilol
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
Bleomycin
2
salicylhydroxamic acid
1
oblimersen
1
hydrocortisone hemisuccinate
1
dapagliflozin
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Tablets
1
Silymarin
1
Reverse Transcriptase Polymerase Chain Reaction
1
Resistance Training
1
Pulse Wave Analysis
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiotoxicity
×
Palliative Care
×
Clear all
NCT04598646
2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA
Completed
30 enrolled